BioCina to scale up novel bioseparation technology
Pharmaceutical and vaccine company BioCina is planning to scale up from laboratory to industrial scale a bioseparation resin technology for the large-scale production of complex medicines made from biopharmaceuticals. Backed by an Australian Economy Accelerator (AEA) grant, Griffith University Institute for Biomedicine and Glycomics Principal Research Leader, Professor Bernd Rehm and his team are leading…
Details